Infection | Consideration |
---|---|
|
If not high-risk, the testing guidelines recommend HBsAg testing only, with further testing with HBeAg and HBV DNA if HBsAg positive. |
HIV | Testing should be opt-out to ensure all women have access to HIV testing in pregnancy as a routine, however informed consent must be confirmed before testing. Repeat test if patient exposed within previous 12 weeks (window period). |
Syphilis | If clinical suspicion of syphilis, refer to the syphilis guideline. |
Chlamydia | Consider self-collection of samples for testing.
Treatment during pregnancy is recommended. |
HBsAg – Hepatitis B surface antigen |
If test results are positive, refer to STI management section for advice on:
In the event of a positive test result for syphilis or chlamydia, TOC should be considered following treatment. Contact tracing for all sexual partners is essential.
Where continued risk is identified during pregnancy, consider retesting prior to delivery (about 36 weeks).
Even if all test results are negative, use the opportunity to: